Deutsche Maintains Buy Rating on British American Tobacco p.l.c. - Depositary Receipt (BTI)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 29 2025
0mins
Should l Buy BTI?
Source: NASDAQ.COM
Analyst Recommendation: Deutsche Bank has reiterated a "Buy" recommendation for British American Tobacco p.l.c. - Depositary Receipt (NYSE:BTI) as of November 28, 2025, with an average one-year price target of $59.49/share, indicating a potential upside of 1.42%.
Institutional Ownership Growth: There has been a notable increase in institutional ownership of BTI, with 901 funds reporting positions, a 6.12% rise from the previous quarter, and total shares owned by institutions increasing by 5.52% to 382,052K shares.
Positive Fund Sentiment: The put/call ratio for BTI stands at 0.61, suggesting a bullish outlook among investors, with several major funds increasing their allocations significantly over the last quarter.
Projected Financial Performance: British American Tobacco p.l.c. is projected to achieve annual revenue of $31,773 million, reflecting a 24.13% increase, with a non-GAAP EPS forecast of 4.87.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BTI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BTI
About BTI
British American Tobacco p.l.c. is a global multi-category consumer goods business company. The Company provides tobacco and nicotine products. Its segments include the United States, Asia Pacific Middle East and Africa, and Americas and Europe. Its product categories include Vapor, Heating Products (HPs), Modern Oral, Traditional Oral, and Combustible cigarettes. Vapor products are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, known as vapor. HPs are devices that use heat to generate a nicotine-containing aerosol, which the user inhales. This category includes Tobacco Heated Products and Herbal Products for Heating (HPH). Modern Oral products are smoke-free oral nicotine products called nicotine pouches, designed for use in the mouth. Traditional oral products include snus and snuff. Its brands include Vuse, glo, Velo, Grizzly, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, Camel, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Smart Investing: Three High Dividend Stocks to Buy Now
- Oil Price Rebound: Occidental Petroleum, despite being affected by recent Middle East conflicts, remains below its 2022 highs with a current market cap of $56 billion and a dividend yield of 1.7%; as oil prices rise, it is expected to generate outsized profits, enhancing portfolio resilience against inflation.
- Digital Banking Recovery: Ally Financial offers a 3.3% dividend yield; although it has not increased dividends in recent years due to rising interest rates, its net income is nearing $1 billion, and management plans to resume stock buybacks, which is likely to drive gradual dividend growth and attract long-term investors.
- Tobacco Industry Transformation: British American Tobacco boasts a 5.4% dividend yield and is actively expanding into new product categories like e-cigarettes and nicotine pouches, with revenue expected to grow 3% to 5% by 2026, positioning it as a strong cash generator in the future.
- Long-Term Investment Value: While Occidental Petroleum, Ally Financial, and British American Tobacco may not be as exciting as today's hottest AI stocks, their stable earnings power suggests they will be excellent dividend stocks for long-term investment portfolios.
See More
SMITH THOMAS W Significantly Reduces Yelp Holdings
- Share Reduction Details: According to an SEC filing dated February 17, 2026, SMITH THOMAS W reduced its position in Yelp by 96,280 shares during Q4, resulting in a $4.09 million decline in value, reflecting both the sale and stock price changes, indicating a cautious outlook on Yelp's future performance.
- Remaining Stake Proportion: After the reduction, SMITH THOMAS W's remaining stake in Yelp constitutes only 0.22% of its 13F AUM, suggesting a significant loss of confidence in Yelp's investment potential, which may influence market perceptions of the company.
- Top Holdings Analysis: As of February 17, 2026, SMITH THOMAS W's top holdings include CACC valued at $42.08 million (38.9% of AUM), W at $23.81 million (22.0% of AUM), and BTI at $22.51 million (20.8% of AUM), demonstrating a diversified investment strategy and preference for other companies.
- Yelp Market Performance: As of February 17, 2026, Yelp's stock price stood at $20.68, down 45.7% over the past year, underperforming the S&P 500 by 56.53 percentage points, reflecting the challenges it faces in a competitive market environment.
See More
SMITH THOMAS W Reduces Yelp Holdings by 96,280 Shares
- Share Reduction Details: SMITH THOMAS W sold 96,280 shares of Yelp in Q4 2026, resulting in a $4.09 million decline in position value, reflecting both stock price fluctuations and the sale itself.
- Asset Management Impact: This transaction represented a 2.75% decrease in the fund's 13F reportable assets under management (AUM), with the remaining Yelp stake now accounting for only 0.22% of AUM, thus falling outside the fund's top five holdings.
- Stock Performance Analysis: As of February 17, 2026, Yelp's stock price stood at $20.68, down 45.7% over the past year, significantly underperforming the S&P 500 by 56.53 percentage points, indicating a pessimistic market outlook on its growth potential.
- Business Model Overview: Yelp operates as a leading online platform connecting consumers with local businesses through a mix of advertising and digital solutions, with its scalable business model supported by a large user base and diverse service offerings that drive recurring revenue streams.
See More
Tobacco Stocks' Appeal Amid Economic Uncertainty
- Stable Cash Flows: Tobacco stocks like British American Tobacco and Philip Morris are favored during recessions due to their stable cigarette demand and strong cash flows, attracting investors seeking high dividend yields.
- Strong Growth in Smoke-Free Products: Both British American Tobacco and Philip Morris have achieved significant growth in smoke-free products, with the former known for brands like Dunhill and the latter for Marlboro, offering dividend yields of 5.62% and 3.46%, respectively, both above the S&P 500's average of 1.11%.
- Future Earnings Expectations: According to Zacks estimates, British American Tobacco's annual sales are expected to rise 7% in FY26 to $36.76 billion, while Philip Morris's sales are projected to grow 8% in FY26 to $47.14 billion, indicating strong growth potential.
- Increased Investor Confidence: Over the past 30 days, earnings per share estimates for both tobacco companies have been revised upward, earning them a Zacks Rank #2 (Buy) and being selected by experts as top stocks expected to gain over 100% in the coming year, reflecting strong market confidence in their future performance.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More
Smart Investing: Three High Dividend Stocks to Buy Now
- Oil Price Rebound: Occidental Petroleum, despite being affected by recent Middle East conflicts, remains below its 2022 highs with a current market cap of $56 billion and a dividend yield of 1.7%; as oil prices rise, it is expected to generate outsized profits, enhancing portfolio resilience against inflation.
- Digital Banking Recovery: Ally Financial offers a 3.3% dividend yield; although it has not increased dividends in recent years due to rising interest rates, its net income is nearing $1 billion, and management plans to resume stock buybacks, which is likely to drive gradual dividend growth and attract long-term investors.
- Tobacco Industry Transformation: British American Tobacco boasts a 5.4% dividend yield and is actively expanding into new product categories like e-cigarettes and nicotine pouches, with revenue expected to grow 3% to 5% by 2026, positioning it as a strong cash generator in the future.
- Long-Term Investment Value: While Occidental Petroleum, Ally Financial, and British American Tobacco may not be as exciting as today's hottest AI stocks, their stable earnings power suggests they will be excellent dividend stocks for long-term investment portfolios.
See More
SMITH THOMAS W Significantly Reduces Yelp Holdings
- Share Reduction Details: According to an SEC filing dated February 17, 2026, SMITH THOMAS W reduced its position in Yelp by 96,280 shares during Q4, resulting in a $4.09 million decline in value, reflecting both the sale and stock price changes, indicating a cautious outlook on Yelp's future performance.
- Remaining Stake Proportion: After the reduction, SMITH THOMAS W's remaining stake in Yelp constitutes only 0.22% of its 13F AUM, suggesting a significant loss of confidence in Yelp's investment potential, which may influence market perceptions of the company.
- Top Holdings Analysis: As of February 17, 2026, SMITH THOMAS W's top holdings include CACC valued at $42.08 million (38.9% of AUM), W at $23.81 million (22.0% of AUM), and BTI at $22.51 million (20.8% of AUM), demonstrating a diversified investment strategy and preference for other companies.
- Yelp Market Performance: As of February 17, 2026, Yelp's stock price stood at $20.68, down 45.7% over the past year, underperforming the S&P 500 by 56.53 percentage points, reflecting the challenges it faces in a competitive market environment.
See More
SMITH THOMAS W Reduces Yelp Holdings by 96,280 Shares
- Share Reduction Details: SMITH THOMAS W sold 96,280 shares of Yelp in Q4 2026, resulting in a $4.09 million decline in position value, reflecting both stock price fluctuations and the sale itself.
- Asset Management Impact: This transaction represented a 2.75% decrease in the fund's 13F reportable assets under management (AUM), with the remaining Yelp stake now accounting for only 0.22% of AUM, thus falling outside the fund's top five holdings.
- Stock Performance Analysis: As of February 17, 2026, Yelp's stock price stood at $20.68, down 45.7% over the past year, significantly underperforming the S&P 500 by 56.53 percentage points, indicating a pessimistic market outlook on its growth potential.
- Business Model Overview: Yelp operates as a leading online platform connecting consumers with local businesses through a mix of advertising and digital solutions, with its scalable business model supported by a large user base and diverse service offerings that drive recurring revenue streams.
See More
Tobacco Stocks' Appeal Amid Economic Uncertainty
- Stable Cash Flows: Tobacco stocks like British American Tobacco and Philip Morris are favored during recessions due to their stable cigarette demand and strong cash flows, attracting investors seeking high dividend yields.
- Strong Growth in Smoke-Free Products: Both British American Tobacco and Philip Morris have achieved significant growth in smoke-free products, with the former known for brands like Dunhill and the latter for Marlboro, offering dividend yields of 5.62% and 3.46%, respectively, both above the S&P 500's average of 1.11%.
- Future Earnings Expectations: According to Zacks estimates, British American Tobacco's annual sales are expected to rise 7% in FY26 to $36.76 billion, while Philip Morris's sales are projected to grow 8% in FY26 to $47.14 billion, indicating strong growth potential.
- Increased Investor Confidence: Over the past 30 days, earnings per share estimates for both tobacco companies have been revised upward, earning them a Zacks Rank #2 (Buy) and being selected by experts as top stocks expected to gain over 100% in the coming year, reflecting strong market confidence in their future performance.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More
